Citadel Advisors - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is and the CUSIP is 867328901. A total of 3 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$12,000
+71.4%
22,000
+73.2%
0.00%
Q1 2016$7,000
-46.2%
12,700
-12.4%
0.00%
Q4 2015$13,000
+44.4%
14,500
+34.3%
0.00%
Q3 2015$9,000
-60.9%
10,800
+42.1%
0.00%
Q2 2015$23,000
-70.5%
7,600
-76.1%
0.00%
Q1 2015$78,000
+34.5%
31,800
+39.5%
0.00%
Q4 2014$58,000
-95.5%
22,800
-87.5%
0.00%
-100.0%
Q3 2014$1,302,000
+693.9%
182,300
+626.3%
0.00%
Q2 2014$164,000
+54.7%
25,100
+55.9%
0.00%
Q1 2014$106,00016,1000.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 4,079$2,912,0000.11%
GROUP ONE TRADING, L.P. 714,500$5,102,0000.08%
Citadel Advisors 182,300$1,302,0000.00%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders